脂质体布比卡因在青少年特发性脊柱侧凸后路脊柱融合术后多模式镇痛中的作用:更快更远且阿片类药物更少
这项回顾性对照队列研究纳入119例接受后路脊柱融合术的青少年特发性脊柱侧凸患者,比较术中脂质体布比卡因竖脊肌阻滞联合标准术后疼痛方案(A组)与仅标准方案(B组)的效果。A组总阿片类药物消耗量显著低于B组(44.5 mg vs 70.2 mg),且更多患者仅使用口服阿片类药物(81% vs 41%),A组术后第2天出院比例更高(55% vs 27%),行走距离更远。两组疼痛评分、地西泮需求及恶心呕吐无差异。
要点
- A组总阿片类药物消耗量显著低于B组(44.5 mg vs 70.2 mg)。
- A组仅使用口服阿片类药物的患者比例更高(81% vs 41%)。
- A组术后第2天出院比例更高(55% vs 27%),行走距离更远。
核心结论
- 脂质体布比卡因与青少年特发性脊柱侧凸后路脊柱融合术后阿片类药物使用减少、住院时间缩短和行走改善相关。
- 将脂质体布比卡因纳入多模式疼痛管理方案在减少阿片类药物使用的同时增加了术后早期活动。
研究设计与样本
- 回顾性对照队列研究,纳入119例连续接受后路脊柱融合术的青少年特发性脊柱侧凸患者。
- A组接受术中脂质体布比卡因竖脊肌阻滞联合标准术后疼痛管理方案,B组仅接受标准术后疼痛方案。
主要发现
- A组总阿片类药物消耗量显著低于B组(44.5 mg vs 70.2 mg)。
- A组术后第0天吗啡使用量低于B组,术后第1天和第2天羟考酮使用量低于B组。
- A组仅使用口服阿片类药物的患者比例高于B组(81% vs 41%)。
- 需要静脉阿片类药物的患者中,79%未接受脂质体布比卡因。
- A组术后第2天出院比例高于B组(55% vs 27%),住院时间更短,术后行走距离更远。
临床怎么用
- 作者结论认为脂质体布比卡因与阿片类药物使用减少、住院时间缩短和行走改善相关,将脂质体布比卡因纳入多模式疼痛管理方案在减少阿片类药物使用的同时增加了术后早期活动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective controlled cohort. OBJECTIVE: To evaluate the effect of intraoperative liposomal bupivacaine (LB) infiltration on postsurgical pain management in adolescent idiopathic scoliosis (AIS) patients by analyzing postoperative opioid consumption, ambulation, and length of stay (LOS). SUMMARY OF BACKGROUND DATA: Optimal postoperative pain control for AIS patients undergoing posterior spinal fusion (PSF) is challenging. Multimodal pain management protocols provide adequate analgesia while decreasing opioid consumption. LB was recently approved for pediatric patients; however, use in AIS patients is understudied. METHODS: 119 consecutive patients with AIS who underwent PSF were included. Patients were divided into 2 groups: patients who received LB as erector spinae block in addition to the standard postoperative pain management protocol (Group A), and patients who received only the standard postoperative pain protocol (Group B). Oral morphine equivalents, intravenous opioid and valium consumption, pain scores (VAS), nausea/vomiting, ambulation distance and LOS were assessed. RESULTS: Group A experienced significantly lower total opioid consumption compared to Group B (44.5 mg vs. 70.2 mg). Morphine use was lower in Group A on postoperative day (POD) 0, and oxycodone use was lower in Group A on PODs 1 and 2. There was a higher proportion of patients who used only oral opioids in Group A (81% vs. 41%). Of patients requiring any intravenous opioids, 79% did not receive LB. A significantly higher proportion of LB patients were discharged on POD 2 (55% vs. 27%); therefore, LOS was shorter for Group A. Group A ambulated further postoperatively. There were no differences in pain scores, valium requirements or nausea/vomiting. CONCLUSIONS: LB was associated with decreased total opioid use, shorter LOS, and improved ambulation in AIS patients undergoing PSF. Including LB in multimodal pain management protocols proved effective in reducing opioid use while increasing mobilization in the immediate postoperative period. LEVEL OF EVIDENCE: 3.
引用
- Changoor S, Giakas A, Sacks K, et al. The Role of Liposomal Bupivacaine in Multimodal Pain Management Following Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis: Faster and Farther With Less Opioids. Spine (Phila Pa 1976). 2023. PMID: 37159268. doi:10.1097/BRS.0000000000004702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。